Skip to main content
Top
Published in: Journal of Nuclear Cardiology 4/2017

01-08-2017 | Editorial

Myocardial perfusion imaging with 99mTc-labeled radiopharmaceuticals: How fast can a stress-rest same-day imaging protocol be completed?

Author: Raymond Taillefer, MD, FRCP, ABNM

Published in: Journal of Nuclear Cardiology | Issue 4/2017

Login to get access

Excerpt

Since its first clinical introduction in the early 1990s, myocardial perfusion imaging (MPI) with either 99mTc-Sestamibi (Cardiolite) or 99mTc-Tetrofosmin (Myoview) has been the subject of several types of imaging protocols.1 Although various parameters must be taken into consideration before establishing a specific imaging protocol, achievement of the highest overall diagnostic accuracy in the safest way for the patient must remain the major goal. In the actual highly “competitive” healthcare environment, obtaining a diagnosis in the easiest, safest, fastest, and less expensive way has almost become mandatory. Most of the non-nuclear cardiologic diagnostic procedures can be completed within 1 hour while a complete same-day MPI protocol still requires a longer time, no matter if a rest-stress or stress-rest injection sequence is used,2 unless a stress-only protocol is performed. Most of the current MPI protocols are modulated from two general parameters: pharmacokinetics of the radiopharmaceuticals and the type of detector-software combination used in the imaging data acquisition and analysis process. In recent years, researches have been focused on the development of dedicated cardiac systems showing potential benefits such as patient comfort, shorter acquisition time, and/or reduced administered activity.3-5 In comparison with the traditional scintillation detector technology, novel detector technology such as pixelated solid-state CZT (an alloy of cadmium telluride and zinc telluride) detectors offers a better energy resolution and a virtually linear count rate response. This new type of detector has demonstrated similar performance as traditional systems, but with significant shorter imaging times or lower administered radioactivity, achieving a reduction in absorbed dose to 1 mSv for a single injection of MPI radiotracer.6 Another variation from traditional design is the upright position offered in some dedicated systems.7 Other camera systems offer a rotating chair instead of a rotating gantry or special detectors to allow for optional x-ray-based attenuation correction. Another upgraded technology uses a conventional multi-purpose SPECT system with a cardio-focal collimator and a specific reconstruction algorithm allowing for reduction in acquisition times with no loss in image quality. …
Literature
1.
go back to reference Wackers FJT. The maze of myocardial perfusion imaging protocols in 1994. J Nucl Cardiol 1994;1:180-8.CrossRef Wackers FJT. The maze of myocardial perfusion imaging protocols in 1994. J Nucl Cardiol 1994;1:180-8.CrossRef
2.
go back to reference Taillefer R, Gagnon A, Laflamme L, Grégoire J, Léveillé J, Phaneuf DC. Same day injection of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: Comparison between rest-stress and stress-rest injection sequences. Eur J Nucl Med 1989;15:113-7.PubMed Taillefer R, Gagnon A, Laflamme L, Grégoire J, Léveillé J, Phaneuf DC. Same day injection of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: Comparison between rest-stress and stress-rest injection sequences. Eur J Nucl Med 1989;15:113-7.PubMed
3.
go back to reference Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: New designs and clinical implications. J Nucl Med 2011;52:210-7.CrossRef Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: New designs and clinical implications. J Nucl Med 2011;52:210-7.CrossRef
4.
go back to reference DePuey EG. Advances in SPECT gamma camera software and hardware: Currently available and new on the horizon. J Nucl Cardiol 2012;19:551-81.CrossRef DePuey EG. Advances in SPECT gamma camera software and hardware: Currently available and new on the horizon. J Nucl Cardiol 2012;19:551-81.CrossRef
6.
go back to reference Einstein AJ, Blankstein R, Andrews H, Fish M, Padgett R, Hayes SW, et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: The MILLISIEVERT study. J Nucl Med 2014;55:1430-7.CrossRef Einstein AJ, Blankstein R, Andrews H, Fish M, Padgett R, Hayes SW, et al. Comparison of image quality, myocardial perfusion, and left ventricular function between standard imaging and single-injection ultra-low-dose imaging using a high-efficiency SPECT camera: The MILLISIEVERT study. J Nucl Med 2014;55:1430-7.CrossRef
7.
go back to reference Ben-Haim S, Almukhailed O, Neill J, Slomka P, Allie R, Shiti D, et al. Clinical value of supine and upright myocardial perfusion imaging in obese patients using the D-SPECT camera. J Nucl Cardiol 2014;21:8.CrossRef Ben-Haim S, Almukhailed O, Neill J, Slomka P, Allie R, Shiti D, et al. Clinical value of supine and upright myocardial perfusion imaging in obese patients using the D-SPECT camera. J Nucl Cardiol 2014;21:8.CrossRef
8.
go back to reference Taillefer R. Technetium-99m Sestamibi, in New radiotracers in cardiac imaging: principles and applications. Taillefer-Tamaki: Appleton and Lange; 1999. p. 3-48. Taillefer R. Technetium-99m Sestamibi, in New radiotracers in cardiac imaging: principles and applications. Taillefer-Tamaki: Appleton and Lange; 1999. p. 3-48.
9.
go back to reference Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis-2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-11.PubMed Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis-2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 1989;30:301-11.PubMed
10.
go back to reference Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, et al. Technetium-99m-1,2-bis(2-ethoxyethyl)phosphino)ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.PubMed Higley B, Smith FW, Smith T, Gemmell HG, Das Gupta P, Gvozdanovic DV, et al. Technetium-99m-1,2-bis(2-ethoxyethyl)phosphino)ethane: Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med 1993;34:30-8.PubMed
11.
go back to reference Taillefer R, Lambert R, Dupras G, Grégoire J, Léveillé J, Essiambre R, et al. Clinical comparison between thallium-201 and Tc-99m- methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. Eur J Nucl Med 1989;15:280-6.CrossRef Taillefer R, Lambert R, Dupras G, Grégoire J, Léveillé J, Essiambre R, et al. Clinical comparison between thallium-201 and Tc-99m- methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease. Eur J Nucl Med 1989;15:280-6.CrossRef
12.
go back to reference Francheschi M, Guimond J, Zimmerman RE, Picard MV, English RJ, Carvalho PA, et al. Myocardial clearance of Tc-99m hexakis-2-methoxy-2-methylpropyl isonitrile (MIBI) in patients with coronary artery disease. Clin Nucl Med 1990;5:307-12.CrossRef Francheschi M, Guimond J, Zimmerman RE, Picard MV, English RJ, Carvalho PA, et al. Myocardial clearance of Tc-99m hexakis-2-methoxy-2-methylpropyl isonitrile (MIBI) in patients with coronary artery disease. Clin Nucl Med 1990;5:307-12.CrossRef
13.
go back to reference Hurwitz GA, Clark EM, Slomka PJ, Siddiq SK. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with 99mTc-sestamibi. Clin Nucl Med 1993;18:735-41.CrossRef Hurwitz GA, Clark EM, Slomka PJ, Siddiq SK. Investigation of measures to reduce interfering abdominal activity on rest myocardial images with 99mTc-sestamibi. Clin Nucl Med 1993;18:735-41.CrossRef
14.
go back to reference Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao SS. ASNC imaging guidelines for nuclear cardiology procedures: Stress protocols and tracers. J Nucl Cardiol 2009;16:331-44.CrossRef Henzlova MJ, Cerqueira MD, Hansen CL, Taillefer R, Yao SS. ASNC imaging guidelines for nuclear cardiology procedures: Stress protocols and tracers. J Nucl Cardiol 2009;16:331-44.CrossRef
15.
16.
go back to reference Taillefer R, Lambert R, Bisson G. Myocardial technetium-99m-labeled sestamibi single-photon emission computed tomographic imaging in the detection of coronary artery disease: Comparison between early (15 minutes) and delayed (60 minutes) imaging. J Nucl Cardiol 1994;1:441-8.CrossRef Taillefer R, Lambert R, Bisson G. Myocardial technetium-99m-labeled sestamibi single-photon emission computed tomographic imaging in the detection of coronary artery disease: Comparison between early (15 minutes) and delayed (60 minutes) imaging. J Nucl Cardiol 1994;1:441-8.CrossRef
17.
go back to reference Giorgetti A, Rosi M, Stanislao M, Valle G, Bertolaccini P, Maneschi A, et al. Feasibility and diagnostic accuracy of a gated SPECT early-imaging protocol: A multicenter study of the Myoview imaging optimization group. J Nucl Med 2007;48:1670-5.CrossRef Giorgetti A, Rosi M, Stanislao M, Valle G, Bertolaccini P, Maneschi A, et al. Feasibility and diagnostic accuracy of a gated SPECT early-imaging protocol: A multicenter study of the Myoview imaging optimization group. J Nucl Med 2007;48:1670-5.CrossRef
18.
go back to reference Philippe L, Merino B, Blaire T, Bailliez A, Casset-Senon D, Levy M, et al. Tetrofosmin early time gated post-stress single=photon emission computed tomography imaging: Feasibility and potential benefits. J Nucl Cardiol 2011;18:62-72.CrossRef Philippe L, Merino B, Blaire T, Bailliez A, Casset-Senon D, Levy M, et al. Tetrofosmin early time gated post-stress single=photon emission computed tomography imaging: Feasibility and potential benefits. J Nucl Cardiol 2011;18:62-72.CrossRef
19.
go back to reference Mut F, Giubbini R, Vitola J, Lusa L, Sobic-Saranovic D, Peix A, et al. Detection of post-exercise stunning by early gated SPECT myocardial perfusion imaging: results from the IAEA multi-center study. J Nucl Cardiol 2014;21:1168-76.CrossRef Mut F, Giubbini R, Vitola J, Lusa L, Sobic-Saranovic D, Peix A, et al. Detection of post-exercise stunning by early gated SPECT myocardial perfusion imaging: results from the IAEA multi-center study. J Nucl Cardiol 2014;21:1168-76.CrossRef
20.
go back to reference Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.CrossRef Johnson LL, Verdesca SA, Aude WY, Xavier RC, Nott LT, Campanella MW, et al. Postischemic stunning can affect left ventricular ejection fraction and regional wall motion on post-stress gated sestamibi tomograms. J Am Coll Cardiol 1997;30:1641-8.CrossRef
21.
go back to reference Toba M, Kumita S, Cho K, Ibuki C, Kumazaki T, Takano T. Usefulness of gated myocardial perfusion SPECT imaging soon after exercise to identify postexercise stunning in patients with single-vessel coronary artery disease. J Nucl Cardiol 2004;11:697-703.CrossRef Toba M, Kumita S, Cho K, Ibuki C, Kumazaki T, Takano T. Usefulness of gated myocardial perfusion SPECT imaging soon after exercise to identify postexercise stunning in patients with single-vessel coronary artery disease. J Nucl Cardiol 2004;11:697-703.CrossRef
22.
go back to reference Sciagra R, Sotgia B, Dona M, Pupi A. Influence of the postexercise acquisition delay on the detection of functional abnormalities in sestamibi-gated SPECT. J Nucl Cardiol 2007;14:334-40.CrossRef Sciagra R, Sotgia B, Dona M, Pupi A. Influence of the postexercise acquisition delay on the detection of functional abnormalities in sestamibi-gated SPECT. J Nucl Cardiol 2007;14:334-40.CrossRef
23.
go back to reference Narra RK, Feld T, Nunn AD. Absorbed radiation dose to humans from Technetium-99m-Teboroxime. J Nucl Med 1992;33:88-93.PubMed Narra RK, Feld T, Nunn AD. Absorbed radiation dose to humans from Technetium-99m-Teboroxime. J Nucl Med 1992;33:88-93.PubMed
Metadata
Title
Myocardial perfusion imaging with 99mTc-labeled radiopharmaceuticals: How fast can a stress-rest same-day imaging protocol be completed?
Author
Raymond Taillefer, MD, FRCP, ABNM
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Journal of Nuclear Cardiology / Issue 4/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-016-0461-z

Other articles of this Issue 4/2017

Journal of Nuclear Cardiology 4/2017 Go to the issue